Morning Buzz: Galectin Therapeutics (GALT), Achillion Pharmaceuticals (ACHN), GoPro (GPRO), Alibaba (BABA), BlackBerry (BBRY)

Shares of Galectin Therapeutics, Inc. (GALT) are up almost 14% to $6.00 in pre-market trading Monday after the company presented data from its Phase 1 clinical trial of GR-MD-02 in NASH (fatty liver disease) patients with advanced fibrosis at The Liver Meeting in Boston, Massachusetts. Galecting said that overall, data from the multi-center, partially blinded […] View the full post at: Morning Buzz: Galectin Therapeutics (GALT), Achillion Pharmaceuticals (ACHN), GoPro (GPRO), Alibaba (BABA), BlackBerry (BBRY) No related posts.